Drugs / CYTOIMPLANT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00003780 | Dec 1998 → ? | malignant pancreatic neoplasm | Meyer Pharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CYTOIMPLANT | “OBJECTIVES: I. Compare the efficacy of CYTOIMPLANT (intratumor implants of allogeneic peripheral blood mononuclear cells sensitized against patient alloantigens by mixed...” NCT00003780 ↗ |
| Modality | Cell therapy | “intratumor implants of allogeneic peripheral blood mononuclear cells sensitized against patient alloantigens by mixed lymphocyte culture” NCT00003780 ↗ |
| Route | Other | “The mixture is implanted into the tumor using endoscopic ultrasound guided fine needle injection.” NCT00003780 ↗ |